| DB ID | MyCo_3771 |
| Title | Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing |
| Year | 2014 |
| PMID | 24489964 |
| Fungal Diseases involved | Invasive fusariosis |
| Associated Medical Condition | None |
| Genus | Fusarium |
| Species | oxysporum |
| Organism | Fusarium oxysporum |
| Ethical Statement | The study was approved by the institutions’ ethical committees, and a waiver of the need for written informed consent was granted, because of the observa- tional nature of the study: Comite de Etica em Pesquisa do Hospital Universita ´rio Clementino Fraga Filho and Comite de Etica em Pesquisa da Unifesp/EPM. |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | GM |
| Biomarker Full Name | Galactomannan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Brazil |
| Cohort | Between 2008 and 2012, 25 cases of invasive fusariosis were diagnosed in the three institutions. Seven cases were excluded; four because no GMI tests were performed in the period, and three because the closest GMI test was .2 days from the date of the first clinical manifestation of invasive fusariosis. The main characteristics of the remaining 18 cases. |
| Cohort No. | 18 |
| Age Group | 10–69 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Assay |
| Analysis Method | GM Assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | GM Assay |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
